Clinical Trial Update: Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of exenatide weekly in adolescents with type 2 diabetes has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus in Children and Adolescents

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: AstraZeneca | Conditions: Children and Adolescent With Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2020-12-03